SMN2 and myotonic dystrophy type 1: Treatment-naïve SMA individuals, control individuals, and individuals with DMD and DM1 showed baseline plasma pNF-H levels < BLQ, as well as asymptomatic siblings identified through newborn screening and possessing 4 SMN2 copies.